Malaysia · Delayed Price · Currency is MYR Genetec Technology Berhad Statistics
Total Valuation
KLSE:GENETEC has a market cap or net worth of MYR 266.73 million. The enterprise value is 327.49 million.
| Market Cap | 266.73M |
| Enterprise Value | 327.49M |
Important Dates
The next estimated earnings date is Tuesday, September 1, 2026.
| Earnings Date | Sep 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:GENETEC has 773.12 million shares outstanding. The number of shares has decreased by -1.07% in one year.
| Current Share Class | 773.12M |
| Shares Outstanding | 773.12M |
| Shares Change (YoY) | -1.07% |
| Shares Change (QoQ) | -0.28% |
| Owned by Insiders (%) | 22.25% |
| Owned by Institutions (%) | 21.26% |
| Float | 556.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.59 |
| PS Ratio | 2.59 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.10 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.54 |
| Interest Coverage | -35.44 |
Financial Efficiency
Return on equity (ROE) is -40.11% and return on invested capital (ROIC) is -40.06%.
| Return on Equity (ROE) | -40.11% |
| Return on Assets (ROA) | -18.88% |
| Return on Invested Capital (ROIC) | -40.06% |
| Return on Capital Employed (ROCE) | -48.89% |
| Weighted Average Cost of Capital (WACC) | 7.81% |
| Revenue Per Employee | 298,104 |
| Profits Per Employee | -420,151 |
| Employee Count | 345 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 16.03 |
Taxes
In the past 12 months, KLSE:GENETEC has paid 240,000 in taxes.
| Income Tax | 240,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.51% in the last 52 weeks. The beta is 0.97, so KLSE:GENETEC's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -48.51% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 46.65 |
| Average Volume (20 Days) | 23,440,795 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:GENETEC had revenue of MYR 102.85 million and -144.95 million in losses. Loss per share was -0.19.
| Revenue | 102.85M |
| Gross Profit | -116.37M |
| Operating Income | -140.68M |
| Pretax Income | -144.71M |
| Net Income | -144.95M |
| EBITDA | -134.66M |
| EBIT | -140.68M |
| Loss Per Share | -0.19 |
Balance Sheet
The company has 39.46 million in cash and 100.48 million in debt, with a net cash position of -61.02 million or -0.08 per share.
| Cash & Cash Equivalents | 39.46M |
| Total Debt | 100.48M |
| Net Cash | -61.02M |
| Net Cash Per Share | -0.08 |
| Equity (Book Value) | 287.00M |
| Book Value Per Share | 0.37 |
| Working Capital | 134.48M |
Cash Flow
In the last 12 months, operating cash flow was -41.93 million and capital expenditures -23.52 million, giving a free cash flow of -65.45 million.
| Operating Cash Flow | -41.93M |
| Capital Expenditures | -23.52M |
| Depreciation & Amortization | 6.02M |
| Net Borrowing | 67.78M |
| Free Cash Flow | -65.45M |
| FCF Per Share | -0.08 |
Margins
Gross margin is -113.15%, with operating and profit margins of -136.78% and -140.94%.
| Gross Margin | -113.15% |
| Operating Margin | -136.78% |
| Pretax Margin | -140.71% |
| Profit Margin | -140.94% |
| EBITDA Margin | -130.93% |
| EBIT Margin | -136.78% |
| FCF Margin | n/a |
Dividends & Yields
KLSE:GENETEC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.07% |
| Shareholder Yield | 1.07% |
| Earnings Yield | -54.34% |
| FCF Yield | -24.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 7, 2022. It was a forward split with a ratio of 13.
| Last Split Date | Jan 7, 2022 |
| Split Type | Forward |
| Split Ratio | 13 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |